MyBreathPrint for Lung Nodule Classification
Early detection/Lung Cancer (Pulmonary Nodule Malignancy)
Clinical ValidationActive
Key Facts
Indication
Early detection/Lung Cancer (Pulmonary Nodule Malignancy)
Phase
Clinical Validation
Status
Active
Company
About Vocxi Health
Vocxi Health is pioneering a transformative, non-invasive diagnostic platform centered on its MyBreathPrint® system. Inspired by canine olfaction, the technology uses a proprietary sensor array and machine learning to detect disease-specific VOC patterns in breath with parts-per-billion sensitivity, initially targeting lung cancer. The company, a spin-out from a medical device leader and world-class research hospital, is in the clinical validation stage and has garnered significant recognition through awards and nominations, positioning itself to disrupt traditional screening paradigms.
View full company profile